Aspira Women's Health Management
Management criteria checks 1/4
Aspira Women's Health's CEO is Sandy Milligan, appointed in Apr 2024, has a tenure of less than a year. total yearly compensation is $447.98K, comprised of 60% salary and 40% bonuses, including company stock and options. directly owns 0.082% of the company’s shares, worth €4.96K. The average tenure of the management team and the board of directors is 1.2 years and 1.5 years respectively.
Key information
Sandy Milligan
Chief executive officer
US$448.0k
Total compensation
| CEO salary percentage | 60.0% |
| CEO tenure | less than a year |
| CEO ownership | 0.08% |
| Management average tenure | 1.2yrs |
| Board average tenure | 1.5yrs |
Recent management updates
Recent updates
CEO
Sandy Milligan (59 yo)
less than a year
Tenure
US$447,981
Compensation
Dr. Sandra Milligan, M.D. J.D., also Known as Sandy, serves as President of Aspira Women's Health Inc. since April 01, 2024 and serves as its Interim CEO since December 16, 2024. She serves as an Independe...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & President | less than a year | US$447.98k | 0.082% € 5.0k | |
| Senior Vice President of Human Resources | 2.9yrs | no data | no data | |
| Senior Vice President of Commercial Strategy & Operations | 1.5yrs | no data | no data | |
| Senior Vice President of Commercial Operations | less than a year | no data | no data |
1.2yrs
Average Tenure
Experienced Management: CUL's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | less than a year | US$25.54k | 0.75% € 45.5k | |
| Independent Director | 1.8yrs | US$60.28k | 0.35% € 21.1k | |
| Independent Chair of the Board | 1.8yrs | US$80.89k | 0.34% € 20.8k | |
| Independent Director | 1.8yrs | US$63.16k | 0.37% € 22.2k | |
| Independent Director | 1.7yrs | US$58.72k | 0.37% € 22.2k | |
| Member of Scientific Advisory Board | no data | US$484.75k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 3yrs | US$57.58k | 0.30% € 18.4k | |
| Chairman of Clinical Advisory Board | 1.3yrs | no data | no data | |
| Member of Clinical Advisory Board | 1.3yrs | no data | no data | |
| Member of Clinical Advisory Board | 1.3yrs | no data | no data | |
| Member of Clinical Advisory Board | 1.3yrs | no data | no data |
1.5yrs
Average Tenure
67yo
Average Age
Experienced Board: CUL's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/02 00:29 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Aspira Women's Health Inc. is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| James Molloy | Alliance Global Partners |
| Benjamin Haynor | Alliance Global Partners |
| Laura McGuigan | B. Riley Securities, Inc. |